Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIT-REZ-2005: Therapy Optimization for Relapsed Pediatric Brain Tumors
NCT00749723Phase 3Completed
- Sponsor
- University Hospital Bonn
- Start
- Feb 2006
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temozolomide, etoposide in medulloblastoma, primitive neuroectodermal tumor (PNET), ependymoma, sponsored by University Hospital Bonn. Started Feb 2006; status: completed.
02
Drugs
temozolomideetoposide
03
Conditions
medulloblastomaprimitive neuroectodermal tumor (PNET)ependymoma
Beyond the preview
Go deeper on NCT00749723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00749723.